17hon MSN
Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma ...
MMRF continues to drive the critical global research collaborations that lead to scientific breakthroughs and improved patient outcomesNORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the ...
News Medical on MSN
Iron Wields Power Against Multiple Myeloma Cells
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer ...
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy ...
Earlier this month, the FDA approved Bildyos and Bilprevda (denosumab-nxxp), 2 additional denosumab biosimilars for Prolia ...
Bristol Myers Squibb (BMY) announced on Tuesday that a late-stage study evaluating Iberdomide in patients with relapsed or ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today ...
The unfolded protein response (UPR) is a protective pathway that helps cells manage stress during protein production. Cancer cells exploit this ...
An announcement from Telo Genomics Corp ( ($TSE:TELO) ) is now available. Telo Genomics Corp presented a new methodology for evaluating minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback